CD4 and tuberculosis: As shown in the table, there was no statistical significant difference in the proportion of patients initiated on ART within 14 days of eligibility between START-ART intervention and the sustainability period among the patients who had tuberculosis at start of ART treatment, CD4 less or equal to 50 cells/mm3, and eligibility WHO stages 3 and 4 (Table 2).